Functionalized 129Xe contrast agents for magnetic resonance imaging

Current Opinion in Chemical Biology

Volumn 14, Issue 1, 2010, Pages 97-104

  Taratula, Olena ^a   Dmochowski, Ivan J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CONTRAST MEDIUM; ENZYME; OLIGONUCLEOTIDE; PROTEIN DERIVATIVE; STREPTAVIDIN; UNCLASSIFIED DRUG; XENON; XENON 129; ZEOLITE;

BIOSENSOR; CONTRAST ENHANCEMENT; HUMAN; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; CHEMISTRY; GENETIC PROCEDURES; METABOLISM; METHODOLOGY;

BIOSENSING TECHNIQUES; CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; XENON ISOTOPES;

EID: 75149134736     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2009.10.009     Document Type: Review

References (63)

1. Spence M.M., Rubin S.M., Dimitrov I.E., Ruiz E.J., Wemmer D.E., Pines A., Yao S.Q., Tian F., and Schultz P.G. Functionalized xenon as a biosensor. Proc Natl Acad Sci USA 98 (2001) 10654-10657
2. Lauterbur P.C. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242 (1973) 190-191
3. Mansfield P., and Grannell P.K. NMR 'diffraction' in solids?. J Phys C: Solid State Phys 6 (1973) L422-L426
4. Chan K.W.-Y., and Wong W.-T. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 251 (2007) 2428-2451
5. Slotkin J., Cahill K., Tharin S., and Shapiro E. Cellular magnetic resonance imaging: Nanometer and micrometer size particles for noninvasive cell localization. Neurotherapeutics 4 (2009) 428-433
6. Urbanczyk-Pearson L.M., Femia F.J., Smith J., Parigi G., Duimstra J.A., Eckermann A.L., Luchinat C., and Meade T.J. Mechanistic investigation of beta-galactosidase-activated MR contrast agents. Inorg Chem 47 (2008) 56-68
7. Perez J.M., Josephson L., and Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 5 (2004) 261-264
8. 19F MRI. Angew Chem-Int Ed 48 (2009) 3641-3643
9. Mugler J.P., Driehuys B., Brookeman J.R., Cates G.D., Berr S.S., Bryant R.G., Daniel T.M., deLange E.E., Downs J.H., Erickson C.J., et al. MR imaging and spectroscopy using hyperpolarized Xe-129 gas: preliminary human results. Magn Res Med 37 (1997) 809-815
10. Golman K., and Petersson J.S. Metabolic imaging and other applications of hyperpolarized C-13. Academic Radiol 13 (2006) 932-942
11. 83Kr MRI of lungs. J Magn Reson 195 (2008) 232-237
12. Hopkins S.R., Levin D.L., Emami K., Kadlecek S., Yu J.S., Ishii M., and Rizi R.R. Advances in magnetic resonance imaging of lung physiology. J Appl Physiol 102 (2007) 1244-1254
13. Berthault P., Huber G., and Desvaux H. Biosensing using laser-polarized xenon NMR/MRI. Prog Nucl Magn Reson Spec 55 (2008) 35-60
14. 129Xe. Phys Rev Lett 96 (2006) 053002-053001-053004
15. Clever H.L. Solubility Data Series vol. 2 (1979), Pergamon Press, New York
16. Rathore R., Lindeman S.V., Rao K., Sun D., and Kochi J.K. Guest penetration deep within the cavity of calix[4]arene hosts: the tight binding of nitric oxide to distal (cofacial) aromatic groups. Angew Chem-Int Ed 39 (2000) 2123-2127
17. Bartik K., Luhmer M., Heyes S.J., Ottinger R., and Reisse J. Probing molecular cavities in alpha-cyclodextrin solutions by xenon NMR. J Magn Reson B 109 (1995) 164-168
18. Kim B.S., Ko Y.H., Kim Y., Lee H.J., Selvapalam N., Lee H.C., and Kim K. Water soluble cucurbit[6]uril derivative as a potential Xe carrier for Xe-129 NMR-based biosensors. Chem Commun (2008) 2756-2758
19. Ripmeester J.A., Ratcliffe C.I., and Tse J.S. The nuclear magnetic-resonance of Xe-129 trapped in clathrates and some other solids. J Chem Soc-Faraday Trans I 84 (1988) 3731-3745
20. Robbins T.A., Knobler C.B., Bellew D.R., and Cram D.J. Host-guest complexion .67. A highly adaptive and strongly binding hemicarcerand. J Am Chem Soc 116 (1994) 111-122
21. Fukutomi J., Adachi Y., Kaneko A., Kimura A., and Fujiwara H. Inclusion complex formation of thiacalix[4]arene and Xe in aqueous solution studied by hyperpolarized Xe-129 NMR. J Incl Phenom Macrocyclic Chem 58 (2007) 115-122
22. Gabard J., and Collet A. Synthesis of a (D3)-Bis(cyclotriveratrylenyl) macrocage by stereospecific replication of a (C3)-subunit. J Chem Soc Chem Commun (1981) 1137-1139
23. 1H NMR study of the reversible trapping of xenon by cryptophane-A in organic solution. J Am Chem Soc 120 (1998) 784-791
24. Brotin T., and Dutasta J.P. Cryptophanes and their complexes-present and future. Chem Rev 109 (2009) 88-130
25. -1 at 293 K.
26. Mecozzi S., and Rebek J. The 55% solution: a formula for molecular recognition in the liquid state. Chem Eur J 4 (1998) 1016-1022
27. 129Xe and subsequent chemical exchange with the free xenon.
28. Huber G., Brotin T., Dubois L., Desvaux H., Dutasta J.P., and Berthault P. Water soluble cryptophanes showing unprecedented affinity for xenon: candidates as NMR-based biosensors. J Am Chem Soc 128 (2006) 6239-6246
29. Hill P.A., Wei Q., Eckenhoff R.G., and Dmochowski I.J. Thermodynamics of xenon binding to cryptophane in water and human plasma. J Am Chem Soc 129 (2007) 9262-9263
30. -1 at 293 K, was obtained for cryptophane functionalized with three nearby carboxylates.
31. Brotin T., Devic T., Lesage A., Emsley L., and Collet A. Synthesis of deuterium-labeled cryptophane-A and investigation of Xe@Cryptophane complexation dynamics by 1D-EXSY NMR experiments. Chem Eur J 7 (2001) 1561-1573
32. Spence M.M., Ruiz E.J., Rubin S.M., Lowery T.J., Winssinger N., Schultz P.G., Wemmer D.E., and Pines A. Development of a functionalized xenon biosensor. J Am Chem Soc 126 (2004) 15287-15294
33. 129Xe NMR spectroscopy.
34. 129Xe NMR spectrum showed that in the presence of the complementary strand, the bound xenon signal was shifted upfield by ∼1.5 ppm, whereas it remained unchanged in the presence of the non-complementary strand.
35. 129Xe NMR experiments. A tetra(RGD)-functionalized cryptophane showed cell uptake mediated by integrin.
36. 129Xe NMR resonances of narrow linewidth that were shifted between 3.0 and 7.5 ppm downfield compared with the 'free' biosensor. The NMR spectra clearly distinguished between CA I and II in solution.
37. Wei Q., Seward G.K., Hill P.A., Patton B., Dimitrov I.E., Kuzma N.N., and Dmochowski I.J. Designing Xe-129 NMR biosensors for matrix metalloproteinase detection. J Am Chem Soc 128 (2006) 13274-13283
38. Duhamel G., Choquet P., Grillon E., Lamalle L., Leviel J.L., Ziegler A., and Constantinesco A. Xenon-129 MR imaging and spectroscopy of rat brain using arterial delivery of hyperpolarized xenon in a lipid emulsion. Magn Reson Med 46 (2001) 208-212
39. Ruppert K., Mata J.F., Brookeman J.R., Hagspiel K.D., and Mugler J.P. Exploring lung function with hyperpolarized Xe-129 nuclear magnetic resonance. Magn Reson Med 51 (2004) 676-687
40. Driehuys B., Cofer G.P., Pollaro J., Mackel J.B., Hedlund L.W., and Johnson G.A. Imaging alveolar-capillary gas transfer using hyperpolarized Xe-129 MRI. Proc Natl Acad Sci USA 103 (2006) 18278-18283
41. 129Xe-saturated saline.
42. Goodson B.M., Song Y.Q., Taylor R.E., Schepkin V.D., Brennan K.M., Chingas G.C., Budinger T.F., Navon G., and Pines A. In vivo NMR and MRI using injection delivery of laser-polarized xenon. Proc Natl Acad Sci USA 94 (1997) 14725-14729
43. Venkatesh A.K., Zhao L., Balamore D., Jolesz F.A., and Albert M.S. Evaluation of carrier agents for hyperpolarized xenon MRI. NMR Biomed 13 (2000) 245-252
44. Luhmer M., Goodson B.M., Song Y.Q., Laws D.D., Kaiser L., Cyrier M.C., and Pines A. Study of xenon binding in cryptophane-A using laser-induced NMR polarization enhancement. J Am Chem Soc 121 (1999) 3502-3512
45. Cherubini A., and Bifone A. Hyperpolarised xenon in biology. Prog Nucl Magn Reson Spec 42 (2003) 1-30
46. Wolber J., Rowland I.J., Leach M.O., and Bifone A. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon. Magn Reson Med 41 (1999) 442-449
47. Bifone A., Song Y.Q., Seydoux R., Taylor R.E., Goodson B.M., Pietrass T., Budinger T.F., Navon G., and Pines A. NMR of laser-polarized xenon in human blood. Proc Natl Acad Sci USA 93 (1996) 12932-12936
48. Welsh R.C., Chupp T.E., Coulter K.P., Rosen M.S., and Swanson S.D. Magnetic resonance imaging with laser-polarized Xe-129. Nucl Instrum Methods Phys Res A-Accel Spectrom Det Assoc Equip 402 (1998) 461-463
49. Marx T., Schmidt M., Schirmer U., and Reinelt H. Xenon anaesthesia. J R Soc Med 93 (2000) 513-517
50. Mynar J.L., Lowery T.J., Wemmer D.E., Pines A., and Frechet J.M.J. Xenon biosensor amplification via dendrimer-cage supramolecular constructs. J Am Chem Soc 128 (2006) 6334-6335
51. Mulder W.J.M., Strijkers G.J., van Tilborg G.A.F., Griffioen A.W., and Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 19 (2006) 142-164
52. 129Xe exhibits fairly long relaxation times inside the pores. This is the first paper to look at the distribution of a xenon biosensor in vivo.
53. Harel E., Schroder L., and Xu S. Novel detection schemes of nuclear magnetic resonance and magnetic resonance imaging: applications from analytical chemistry to molecular sensors. Annu Rev Anal Chem 1 (2008) 133-163
54. Lowery T.J., Garcia S., Chavez L., Ruiz E.J., Wu T., Brotin T., Dutasta J.P., King D.S., Schultz P.G., Pines A., et al. Optimization of xenon biosensors for detection of protein interactions. Chembiochem 7 (2006) 65-73
55. Ruiz E.J., Sears D.N., Pines A., and Jameson C.J. Diastereomeric Xe chemical shifts in tethered cryptophane cages. J Am Chem Soc 128 (2006) 16980-16988
56. Moule A.J., Spence M.M., Han S.I., Seeley J.A., Pierce K.L., Saxena S., and Pines A. Amplification of xenon NMR and MRI by remote detection. Proc Natl Acad Sci USA 100 (2003) 9122-9127
57. Sears D.N., and Jameson C.J. Theoretical calculations of the Xe chemical shifts in cryptophane cages. J Chem Phys 119 (2003) 12231-12244
58. 129Xe-cryptophane biosensor complexed with human carbonic anhydrase II. J Am Chem Soc 130 (2008) 6942-6943. The first reported X-ray crystal structure of cryptophane bound to protein (CA) confirms tight binding of biosensor with CAII and the encapsulation of one xenon atom inside of functionalized cryptophane.
59. Schröder L., Chavez L., Meldrum T., Smith M., Lowery T.J., Wemmer D.E., and Pines A. Temperature-controlled molecular depolarization gates in nuclear magnetic resonance. Angew Chem Int Ed 47 (2008) 4316-4320
60. Hilty C., Lowery T.J., Wemmer D.E., and Pines A. Spectrally resolved magnetic resonance imaging of a xenon biosensor. Angew Chem Int Ed 45 (2006) 70-73
61. 129Xe MRI images was achieved between xenon in two different hosts dissolved in two immiscible media by using a gradient echo sequence with interleaved frequency selection.
62. Driehuys B., Moller H.E., Cleveland Z.I., Pollaro J., and Hedlund L.W. Pulmonary perfusion and xenon gas exchange in rats: MR imaging with intravenous injection of hyperpolarized Xe-129. Radiology 252 (2009) 386-393
63. Santyr G.E., Lam W.W., Parra-Robles J.M., Taves T.M., and Ouriadov A.V. Hyperpolarized noble gas magnetic resonance imaging of the animal lung: approaches and applications. J Appl Phys 105 (2009) 102004